Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort

J Mayoral-van Son; M Juncal-Ruiz; V Ortiz-García de la Foz; J Vázquez-Bourgon; E Setién-Suero; D Tordesillas-Gutiérrez; M Gómez-Revuelta; R Ayesa-Arriola; B Crespo-Facorro; PAFIP Research Group

doi:10.1016/j.schres.2021.04.011

Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort

Schizophr Res. 2021 Jun:232:28-30. doi: 10.1016/j.schres.2021.04.011. Epub 2021 May 16.

Authors

J Mayoral-van Son¹, M Juncal-Ruiz², V Ortiz-García de la Foz³, J Vázquez-Bourgon⁴, E Setién-Suero⁵, D Tordesillas-Gutiérrez⁴, M Gómez-Revuelta⁵, R Ayesa-Arriola⁴, B Crespo-Facorro⁶; PAFIP Research Group

Affiliations

¹ Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Spain; Department of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain. Electronic address: jacquelinem.mayoral.sspa@juntadeandalucia.es.
² Department of Psychiatry, University Hospital Marqués de Valdecilla - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain; Department of Psychiatry Sierrallana Hospital, Torrelavega, Cantabria, Spain.
³ Department of Psychiatry, University Hospital Marqués de Valdecilla - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain.
⁴ Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Spain; Department of Psychiatry, University Hospital Marqués de Valdecilla - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain; Department of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain.
⁵ Department of Psychiatry, University Hospital Marqués de Valdecilla - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain; Department of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain.
⁶ Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Spain; Department of Psychiatry, School of Medicine, University of Seville, Spain.

PMID: 34004383
DOI: 10.1016/j.schres.2021.04.011

No abstract available

Keywords: Antipsychotic dose; Recovery; Relapse; Schizophrenia; Treatment discontinuation.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antipsychotic Agents* / therapeutic use
Cohort Studies
Humans
Psychotic Disorders* / drug therapy
Recurrence

Substances

Antipsychotic Agents

Associated data

ClinicalTrials.gov/NCT03481465
ClinicalTrials.gov/NCT03476473
ClinicalTrials.gov/NCT02200588